Patient-reported experience of bleeding events in haemophilia

European Journal of Haematology

Volumn 93, Issue S75, 2014, Pages 19-28

  Flood, Emuella ^a   Pocoski, Jennifer ^b   Michaels, Lisa A ^b   Mccoy, Anne ^c   Beusterien, Kathleen ^a   Sasanè, Rahul ^b  

^a ICON PLC   (United Kingdom)

^b BAYER CORPORATION   (United States)

^c Summit Healthcare Analysis   (United States)

Author keywords

Bleeds; Interviews; Patient reported outcomes; Qualitative; Symptoms

Indexed keywords

ACTIVATED PROTHROMBIN COMPLEX; BLOOD CLOTTING FACTOR 9; RECOMBINANT BLOOD CLOTTING FACTOR 8;

ADOLESCENT; ADULT; ANGER; ARTICLE; BLEEDING; CHILD; CLINICAL ARTICLE; DISEASE SEVERITY; DIZZINESS; FRUSTRATION; HEADACHE; HEMOPHILIA A; HUMAN; INTERVIEW; MALE; PAIN; PARESTHESIA; PERSONAL EXPERIENCE; PRIORITY JOURNAL; QUALITATIVE RESEARCH; RIGIDITY; SCHOOL CHILD; SKIN BRUISING; SKIN TINGLING; SWELLING; THEMATIC ANALYSIS; THERAPY DELAY; COMPLICATION; CROSS-SECTIONAL STUDY; HEMORRHAGE; MIDDLE AGED; PSYCHOLOGY; SELF DISCLOSURE; YOUNG ADULT;

ADOLESCENT; ADULT; CHILD; CROSS-SECTIONAL STUDIES; HEMOPHILIA A; HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; SELF DISCLOSURE; YOUNG ADULT;

EID: 84902952492     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/ejh.12329     Document Type: Article

References (20)

1. National Haemophilia Foundation (NHF). www.haemaphilia.org; http://www.stepsforliving.haemaphilia.org/section1_3_1?expandable=2.
2. Haemophilia Federation of America. http://hemophiliafed.org/who-are-we/about-bleeding-disorders/bleeding-disorders-faqs/ 2012.
3. World Federation of Haemophilia. Guidelines for the management of haemophilia. http://www.wfh.org/2/docs/Publications/Diagnosis_and_Treatment/Guidelines_Mng_Hemophilia.pdf 2005. Accessed March 2012.
4. Thornburg C. Review Article: Hemophilia: challenges with treatment adherence. J Coagul Disord 2009;2:1-4.
5. Nilsson IM, Berntorp E, Lofqvist T, Pettersson H. Twenty-five years' experience of prophylactic treatment in severe haemophilia A and B. J Intern Med 1992;232:25-32.
6. Blanchette VS. Prophylaxis in the haemophilia population. Haemophilia 2010;16(Suppl 5):181-8.
7. Coppola A, DiCapua M, Minno M, Di Palo M, Marrone E, Ierano P, Arturo C, Tufano A, Cerbone A. Treatment of haemophilia: a review of current advances and ongoing issues. J Blood Med 2010;1:183-95.
8. Donadel-Claeyssens S. Current coordinated activities of the PEDNET (European Paediatric Network for Haemophilia Management). Haemophilia 2006;12:124-7.
9. Kreuz W, Escuriola-Ettingshausen C, Funk M, Schmidt H, Kornhuber B. When should prophylactic treatment in patients with haemophilia A and B start? - The German experience. Haemophilia 1998;4:413-7.
10. U.S. Food and Drug Administration (FDA). Guidance for industry on patient-reported outcome measures: use in medical product development to support labelling claims. Fed Reg 2009;74:65132-3.
11. Joffe H, Yardley L. Content and thematic analysis. In: Marks DF, Yardley L, eds. Research Methods for Clinical Health Psychology. London, UK: Sage; 2004:56-68.
12. Kerr C, Nixon A, Wild D. Assessing and demonstrating data saturation in qualitative inquiry supporting patient-reported outcomes research. Expert Rev Pharmacoecon Outcomes Res 2010;10:269-81.
13. Hassan TH, Badr MA, Fattah NR, Badawy SM. Assessment of musculoskeletal function and mood in haemophilia A adolescents: a cross-sectional study. Haemophilia 2011;17:683-8.
14. Leissinger C, Cooper DL, Solem CT; HTRS Investigators. Assessing the impact of age, race, ethnicity and inhibitor status on functional limitations of patients with severe and moderately severe haemophilia A. Haemophilia 2011;17:884-9.
15. U.S. National Institutes of Health. http://clinicaltrial.gov/ct2/results?term=haemaphilia+AND+quality+of+life.
16. Johnson K, Yi Zhou Z. Costs of care in haemophilia and possible implications of health care reform. Hematology Am Soc Hematol Educ Program 2011;201:413-8.
17. Barlow JH, Stapley J, Ellard DR. Living with haemophilia and von Willebrand's: a descriptive qualitative study. Patient Educ Couns 2007;68:235-42.
18. Beeton K, Neal D, Lee C. An exploration of health-related quality of life in adults with haemophilia - a qualitative perspective. Hemophilia 2005;11:123-32.
19. Beeton K, Neal D, Watson T, Lee CA. Parents of children with haemophilia - a transforming experience. Hemophilia 2007;13:570-9.
20. Neufeld E. Impact of acute bleeding on quality of life (QoL) in patients with congenital haemophilia with inhibitors (CHwI) and their families: evaluation of bleed vs. non-bleed day QoL from the Dosing Observational Study in Haemophilia (DOSE) and implications for assessment and prediction. Haemophilia and Thrombosis Research Society 2010.